A record of what Prashanth Tapse said publicly, with the source. Not advice.
“Recommends buying Max Healthcare for the short term, targeting ₹1,165 / ₹1,185 with a stop-loss at ₹1,110. The stock displays strength with higher lows and steady buying interest, trading above key moving averages. Accumulation on dips toward ₹1,120–₹1,125 is advised.”
Prashanth Tapse’s track record (trackable calls only): 94 graded calls · 95% CI 21–40%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.
Entry zone: ₹1,120–₹1,125. The call starts at the first close that comes into it.
Target ₹1,165, stop ₹1,110, as stated.
Window: 30 days, from the call's own horizon word ("for the short term").
The stop ₹1,110 was reached on a close before the target ₹1,165. Miss.
The grader’s working: R3 TRADE_SETUP: entered ₹1125 on 2025-11-10 (stated entry ₹1120–1125 zone, ZONE entry, filled); stop ₹1110 breached at close ₹1098 on 2025-11-10. Window 30 days — rule H4: the quote says "for the short term" (short-term 30 days, medium-term 90, long-term 12 months).
How it played out
How this is worked out- Target or stop first
- The stop was reached on a close before the target was.
- Time to target
- The target was not reached on a close inside the window.
- Worst close against it
- The closing price went as far as 2.40% against the call up to 10 Nov 2025, when the call was decided, measured from the entry price. Closing prices only; an intraday dip is never counted.
From the entry the grade used, on closing prices. This is a record of one past call and is not advice.